Which of the following is NOT true about infiximab:
- a- IL-1 blocker****
- b- used for treatment of severe rheumatoid arthritis c-may increase risk of infections
- d- administered as IV infusion8
- e- postadministration reactions include fever & chills.
The correct answer is "a- IL-1 blocker". Infliximab is a tumor necrosis factor (TNF) alpha inhibitor, not an IL-1 blocker. TNF-alpha is a cytokine that plays a role in inflammation. Infliximab works by blocking the activity of TNF-alpha, which can help to reduce inflammation and tissue damage.
The other statements about infliximab are all true:
b- Used for treatment of severe rheumatoid arthritis:
Infliximab is a biologic medication that is used to treat severe rheumatoid arthritis that has not responded to other treatments.
c- May increase the risk of infections:
Infliximab can increase the risk of infections, including serious infections such as tuberculosis.
d- Administered as IV infusion:
Infliximab is administered as an intravenous (IV) infusion.
e- Postadministration reactions include fever & chills:
Infliximab can cause post-administration reactions, including fever, chills, headache, and nausea.
Labels
pharmacology